Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00707304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
FORTIS-M: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Patients With Non-small Cell Lung Cancer Who Have Failed Two or More Prior Treatment Regimens
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether talactoferrin can improve overall survival in patients with non-small cell lung cancer (NSCLC) who have been previously treated with two or more regimens.
Study identification
- NCT ID
- NCT00707304
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 742 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Mar 2011 (Actual)
- Completion
- Aug 2012 (Actual)
- Last update posted
- Aug 21, 2012
2008 – 2012
United States locations
- U.S. sites
- 29
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Desert Oasis Cancer Center | Casa Grande | Arizona | 85122 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85710 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| Pasco Pinellas Cancer Center | New Port Richey | Florida | 34652 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Cancer Care Specialists of Central Illinois | Decatur | Illinois | 62526 | — |
| Cancer Care & Hematology Specialists of Chicagoland | Niles | Illinois | 60714 | — |
| Central Indiana Cancer Centers | Greenfield | Indiana | 46140 | — |
| Kansas City Cancer Center, LLC | Overland Park | Kansas | 66210 | — |
| NCI, CCR, The Waren Grant Magnuson Clinical Center | Bethesda | Maryland | 20892 | — |
| Newland Medical Associates | Southfield | Michigan | 48075 | — |
| Minnesota Oncology and Hematology, PA | Minneapolis | Minnesota | 55405 | — |
| Washington University School of Medicine | St Louis | Missouri | 63128 | — |
| Southeast Nebraska Cancer Center | Lincoln | Nebraska | 68510 | — |
| NH Oncology-Hematology, PA | Hooksett | New Hampshire | 03106 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Alamance Regional Medical Center | Burlington | North Carolina | 27216 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Rex Cancer Center | Raleigh | North Carolina | 27609 | — |
| Legacy Pharma Research | Bismarck | North Dakota | 58501 | — |
| Signal Point Clinical Research Center | Middletown | Ohio | 45042 | — |
| Kaiser Group Health | Portland | Oregon | 97227 | — |
| Texas Oncology | Dallas | Texas | 75230 | — |
| Texas Oncology | Fort Worth | Texas | 76104 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care | Salem | Virginia | 24153 | — |
| Cancer Care Northwest | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 160 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00707304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2012 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00707304 live on ClinicalTrials.gov.